SUBSCRIBE
SUBSCRIBE

Novartis

NEWS
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Policy
Ex-Priest Sues Novartis AG After Allegedly Suffering Brain Injury From Taking Jakavi
January 20, 2015
 · 
1 min read
Job Trends
270 Jobs Chopped as Novartis AG to Shutter Plant and Outsource to Eli Lilly
January 19, 2015
 · 
2 min read
Here’s Why 5 Billionaire-Led Funds Gobbled Up 3.3 Million Shares of Celldex Stock
Business
Novartis AG, Qualcomm Launch $100 Million Fund for Innovative Health Startups
January 13, 2015
 · 
2 min read
J.P. Morgan: Five Prime CEO Says Experimental Drug to Head Into Six New Tumor Trials Via Bristol-Myers
Business
J.P. Morgan Breaking News: Novartis AG, Google Inc. to Team Up on “Smart” Contact Lens, Says CEO
January 12, 2015
 · 
1 min read
Mylan Inc., Theravance, Inc. Partner Up for $265 Million COPD Pact
U.K. Cancer Drugs Fund Delists Big Pharmas’ Meds; Novartis AG Slams Process
January 9, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
FDA
Novartis AG Submits Two Lung Drugs for FDA Approval; Analysts Question Decision
January 8, 2015
 · 
2 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
Novartis AG Strikes First-of-its-Kind Biotech Deal for Next Generation Drugs
January 7, 2015
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Drug Development
Novartis AG Researchers Claim to Have Discovered “Fountain of Youth” Drug
December 29, 2014
 · 
2 min read
Biogen Idec Alzheimer's Drug Aducanumab Exceeds Expectations
Policy
Vanda Pharmaceuticals, Inc. Leaps After Regaining Drug Rights From Novartis AG
December 23, 2014
 · 
2 min read
Load More
AWARDS
  • 2022 Best Places to Work
  • 2024 Best Places to Work
JOBS
IN THE PRESS
Job Trends
Novartis AG Axes 2,500 Jobs Globally
September 26, 2011
 · 
1 min read
Drug Development
Novartis Pharmaceuticals Corporation Drug Afinitor(R) Effective in Patients With Non-Cancerous Kidney Tumors Associated With TSC in Phase III Trial
September 23, 2011
 · 
15 min read
Job Trends
Novartis AG Plans More Cuts and Consolidation
September 16, 2011
 · 
1 min read
Business
Novartis AG: Strategic Goals on Track; Development Head Officially Quits for Gates Charity
September 13, 2011
 · 
1 min read
Business
Gates Foundation Eyes Novartis AG Head Of Global R&D
September 12, 2011
 · 
1 min read
Pharm Country
Novartis AG Patent Dispute in India Heats Up
September 6, 2011
 · 
1 min read
Policy
FDA Asks Novartis AG for More Data on Gout Drug
August 29, 2011
 · 
1 min read
National Institute for Clinical Excellence (NICE) Backs Leukemia Drug Tasigna After Novartis AG Agrees to Discount
August 18, 2011
 · 
1 min read
Genetown
Awaiting Novartis AG Acquisition, Biotech Firm Proteon Therapeutics, Inc. Raises $15.2 Million
August 12, 2011
 · 
2 min read
How Novartis AG Hopes To Cope With Diovan Patent Expiration
August 5, 2011
 · 
1 min read
Load More